View Single Post
Old 08-22-2016, 10:10 AM   Nav to Top 
Senior Trader
Biohero's Avatar
Join Date: Jan 2012
Location: Frankfurt
Posts: 277
Favorites: Aapl celg onxx
Rep Power: 110
Reputation: 36
Biohero is on a distinguished road

GREAT NEWS OUT .. and stock is stiill terrible underpriced at a market cap of laughable $52 Million .GL

IntelGenx Announces Successful Clinical Study for Montelukast for the Treatment of Degenerative Diseases of the Brain
August 22, 2016

"We are very pleased by the results of the study which confirmed that our Montelukast VersaFilmâ„¢ significantly improves the bioavailability of the drug when given as an oral film product. The study demonstrates that the VersaFilmâ„¢ technology is an effective delivery system for CNS applications," said Dr. Horst G. Zerbe, President and CEO of IntelGenx. "Montelukast is an important drug repurposing opportunity that the company has in its product pipeline which could potentially become a multi-billion-dollar product in the large and underserved market for degenerative diseases of the brain."
Biohero is offline   Rate this post Yes | No Reply With Quote